FDA Approved: IRBESARTAN — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)

View source ↗

Summary

The FDA approved a supplemental application for IRBESARTAN filed by Unichem Pharmaceuticals (USA), Inc., effectively updating the existing ANDA approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Hypertension

Drugs mentioned

• Irbesartan (irbesartan)

Snippet

SUPPL AP for IRBESARTAN (IRBESARTAN)